AC Immune SA
NASDAQ:ACIU

Watchlist Manager
AC Immune SA Logo
AC Immune SA
NASDAQ:ACIU
Watchlist
Price: 2.8 USD -2.78% Market Closed
Market Cap: 277m USD

Wall Street
Price Targets

ACIU Price Targets Summary
AC Immune SA

Wall Street analysts forecast ACIU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACIU is 9.18 USD with a low forecast of 7.07 USD and a high forecast of 12.6 USD.

Lowest
Price Target
7.07 USD
153% Upside
Average
Price Target
9.18 USD
228% Upside
Highest
Price Target
12.6 USD
350% Upside
AC Immune SA Competitors:
Price Targets
HPHA
Heidelberg Pharma AG
62% Upside
301207
Hualan Biological Bacterin Inc
10% Downside
300896
Imeik Technology Development Co Ltd
39% Upside
GNS
Genus PLC
14% Upside
VOR
Vor Biopharma Inc
399% Upside
87S
Roivant Sciences Ltd
14% Upside
IVA
Inventiva SA
253% Upside
688382
InventisBio Co Ltd
73% Upside

Revenue
Forecast

Revenue Estimate
AC Immune SA

For the last 10 years the compound annual growth rate for AC Immune SA's revenue is -1%. The projected CAGR for the next 3 years is 49%.

-1%
Past Growth
49%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
AC Immune SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
AC Immune SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACIU's stock price target?
Price Target
9.18 USD

According to Wall Street analysts, the average 1-year price target for ACIU is 9.18 USD with a low forecast of 7.07 USD and a high forecast of 12.6 USD.

What is AC Immune SA's Revenue forecast?
Projected CAGR
49%

For the last 10 years the compound annual growth rate for AC Immune SA's revenue is -1%. The projected CAGR for the next 3 years is 49%.

Back to Top